Skip to main content
Log in

Treatment of Meningeal Gliomatosis

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To evaluate whether vigorous treatment is beneficial for patients with meningeal gliomatosis (MG) we reviewed the case records of 20 consecutive patients treated for a symptomatic MG in our center. All received systemic or intrathecal chemotherapy and six received additional cranial or spinal radiotherapy. Six patients (30%) achieved a partial response (one low-grade astrocytoma, two anaplastic astrocytomas, one anaplastic oligodendroglioma and two glioblastomas). In these cases, clinical improvement was associated with radiological improvement on CT scan or MRI in five and with a major cerebrospinal fluid improvement in three. Three patients (15%) were stable for 3 months or more and 11 (55%) had progressive disease. Median survival was longer for the responding patients (10 months) than for the other patients (2 months). This study suggests that some patients with MG may benefit from a treatment combining radiotherapy to symptomatic areas and chemotherapy with agents that cross the blood–brain barrier or are delivered directly into the CSF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Davila G, Duyckaerts C, Lazareth JP, Poisson M, Delattre JY: Diffuse primary leptomeningeal gliomatosis. J Neuro Oncol 15: 45-49, 1993

    Google Scholar 

  2. Poisson M, Stragliotto G, Davila G, Duyckaerts C, Delattre JY: Les méningites gliomateuses des tumeurs hémisphériques. Etude de 22 cas chez l'adulte. Rev Neurol (Paris) 151: 177-190, 1995

    Google Scholar 

  3. YungWA, Horten BC, Shapiro WR: Meningeal gliomatosis: a review of 12 cases. Ann Neurol 8: 605-608, 1980

    Google Scholar 

  4. Erlich SS, Davis RL: Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42: 2854-2864, 1978

    Google Scholar 

  5. Vertosick FT, Selker RG: Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 27: 516-522, 1990

    Google Scholar 

  6. Delattre JY, Walker RW, Rosenblum MK: Leptomeningeal gliomatosis with spinal cord or cauda equina compression: a complication of supratentorial gliomas in adults. Acta Neurol Scand 79: 133-139, 1989

    Google Scholar 

  7. Awad I, Bay JW, Rogers L: Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery 19: 247-251, 1986

    Google Scholar 

  8. Arita N, Taneda M, Hayakawa T: Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir (Wien) 126: 84-92, 1994

    Google Scholar 

  9. Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38: 51-57, 1995

    Google Scholar 

  10. Grabb PA, Albright AL, Pang D: Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30: 64-71, 1992

    Google Scholar 

  11. Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F: Symptomatic cerebrospinal fluid dissemination of cerebral glioblastoma. Computed tomographic findings in 11 cases. Neuroradiology 32: 146-150, 1990

    Google Scholar 

  12. Packer RJ, Allen J, Nielsen S, Petito C, Deck M, Jereb B: Brainstem glioma: clinical manifestations of meningeal gliomatosis. Ann Neurol 14: 177-182, 1983

    Google Scholar 

  13. Grant R, Naylor B, Junck L, Greenberg HS: Clinical outcome in aggressively treated meningeal gliomatosis. Neurology 42: 252-254, 1992

    Google Scholar 

  14. McCowage G, Tien R, McLendon R, Felsberg G et al.: Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol 27: 32-39, 1996

    Google Scholar 

  15. Civitello LA, Packer RJ, Rorke LB, Siegel K, Sutton LN, Schut L: Leptomeningeal dissemination of low grade gliomas in childhood. Neurology 38: 562-566, 1988

    Google Scholar 

  16. Siegal T, Lossos A, Pfeffer MR: Leptomeningeal metastases: analysis of 311 patients with sustained off-therapy response following combined-modality therapy. Neurology 44: 1463-1469, 1994

    Google Scholar 

  17. Chamberlain M, Corey-Bloom J: Leptomeningeal metastases: 111Indium-DTPA CSF flow studies. Neurology 41: 1765-1769, 1991

    Google Scholar 

  18. Blasberg R, Patlak C, Fenstermacher J: Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion. Pharmacol Exp Ther 195: 73-83, 1975

    Google Scholar 

  19. Newton HB, Junck L, Bromberg J, Page MA, Greenberg HS: Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Neurology 40: 1743-1746, 1990

    Google Scholar 

  20. Strong JM, Collins JM, Lester C, Poplack DC: Pharmacokinetics of intraventricular and intravenous N, N', N"-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res 46: 6101-6104, 1986

    Google Scholar 

  21. Cairncross JG, Macdonald D, Ludwin S et al.: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12: 2013-2021, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pradat, PF., Hoang-Xuan, K., Cornu, P. et al. Treatment of Meningeal Gliomatosis. J Neurooncol 44, 163–168 (1999). https://doi.org/10.1023/A:1006399804896

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006399804896

Navigation